The main goal was to quantify SP-A and albumin content in exhaled particles from COPD patients, as well as particle number concentrations, in order to evaluate whether the levels differed between patients with COPD and healthy subjects. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.